Jason N. Gorevic

Jason N. Gorevic, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Teladoc Health, Inc. and Kemper Corp. In total, 23 filings cover trades dated from 2 June 2020 to 10 August 2026.

In open-market terms, that means 3 purchases worth €323k on one side and 7 sales worth €4.3M on the other. Sales outweigh purchases by €4.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants and 8 option exercises. Since January 2026: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €112k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 11 August 2026 with an open-market purchase (€112k) in Kemper Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.